澳大利亚妊娠糖尿病协会(ADIPS) 2025对妊娠糖尿病筛查、诊断和分类的共识建议。

IF 8.5 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Arianne Sweeting, Matthew Jl Hare, Susan J de Jersey, Alexis L Shub, Julia Zinga, Cecily Foged, Rosemary M Hall, Tang Wong, David Simmons
{"title":"澳大利亚妊娠糖尿病协会(ADIPS) 2025对妊娠糖尿病筛查、诊断和分类的共识建议。","authors":"Arianne Sweeting, Matthew Jl Hare, Susan J de Jersey, Alexis L Shub, Julia Zinga, Cecily Foged, Rosemary M Hall, Tang Wong, David Simmons","doi":"10.5694/mja2.52696","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In the context of a global obesity and diabetes epidemic, gestational diabetes mellitus and other forms of hyperglycaemia in pregnancy are increasingly common. Hyperglycaemia in pregnancy is associated with short and long term complications for both the woman and her baby. These 2025 consensus recommendations from the Australasian Diabetes in Pregnancy Society (ADIPS) update the guidance for the screening, diagnosis and classification of hyperglycaemia in pregnancy based on available evidence and stakeholder consultation.</p><p><strong>Main recommendations: </strong>Overt diabetes in pregnancy (overt DIP) should be diagnosed at any time in pregnancy if one or more of the following criteria are met: (i) fasting plasma glucose (FPG) ≥ 7.0 mmol/L; (ii) two-hour plasma glucose (2hPG) ≥ 11.1 mmol/L following a 75 g two-hour pregnancy oral glucose tolerance test (POGTT); and/or (iii) glycated haemoglobin (HbA<sub>1c</sub>) ≥ 6.5% (≥ 48 mmol/mol). Irrespective of gestation, gestational diabetes mellitus should be diagnosed using one or more of the following criteria during a 75 g two-hour POGTT: (i) FPG ≥ 5.3-6.9 mmol/L; (ii) one-hour plasma glucose (1hPG) ≥ 10.6 mmol/L; (iii) 2hPG ≥ 9.0-11.0 mmol/L. Women with risk factors for hyperglycaemia in pregnancy should be advised to have the HbA<sub>1c</sub> measured in the first trimester. Women with HbA<sub>1c</sub> ≥ 6.5% (≥ 48 mmol/mol) should be diagnosed and managed as having overt DIP. Before 20 weeks' gestation, and ideally between ten and 14 weeks' gestation, if tolerated, women with a previous history of gestational diabetes mellitus or early pregnancy HbA<sub>1c</sub> ≥ 6.0-6.4% (≥ 42-47 mmol/mol), but without diagnosed diabetes, should be advised to undergo a 75 g two-hour POGTT. All women (without diabetes already detected in the current pregnancy) should be advised to undergo a 75 g two-hour POGTT at 24-28 weeks' gestation.</p><p><strong>Changes in management as a result from this consensus statement: </strong>These updated recommendations raise the diagnostic glucose thresholds for gestational diabetes mellitus and clarify approaches to early pregnancy screening for women with risk factors for hyperglycaemia in pregnancy.</p>","PeriodicalId":18214,"journal":{"name":"Medical Journal of Australia","volume":" ","pages":""},"PeriodicalIF":8.5000,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes.\",\"authors\":\"Arianne Sweeting, Matthew Jl Hare, Susan J de Jersey, Alexis L Shub, Julia Zinga, Cecily Foged, Rosemary M Hall, Tang Wong, David Simmons\",\"doi\":\"10.5694/mja2.52696\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>In the context of a global obesity and diabetes epidemic, gestational diabetes mellitus and other forms of hyperglycaemia in pregnancy are increasingly common. Hyperglycaemia in pregnancy is associated with short and long term complications for both the woman and her baby. These 2025 consensus recommendations from the Australasian Diabetes in Pregnancy Society (ADIPS) update the guidance for the screening, diagnosis and classification of hyperglycaemia in pregnancy based on available evidence and stakeholder consultation.</p><p><strong>Main recommendations: </strong>Overt diabetes in pregnancy (overt DIP) should be diagnosed at any time in pregnancy if one or more of the following criteria are met: (i) fasting plasma glucose (FPG) ≥ 7.0 mmol/L; (ii) two-hour plasma glucose (2hPG) ≥ 11.1 mmol/L following a 75 g two-hour pregnancy oral glucose tolerance test (POGTT); and/or (iii) glycated haemoglobin (HbA<sub>1c</sub>) ≥ 6.5% (≥ 48 mmol/mol). Irrespective of gestation, gestational diabetes mellitus should be diagnosed using one or more of the following criteria during a 75 g two-hour POGTT: (i) FPG ≥ 5.3-6.9 mmol/L; (ii) one-hour plasma glucose (1hPG) ≥ 10.6 mmol/L; (iii) 2hPG ≥ 9.0-11.0 mmol/L. Women with risk factors for hyperglycaemia in pregnancy should be advised to have the HbA<sub>1c</sub> measured in the first trimester. Women with HbA<sub>1c</sub> ≥ 6.5% (≥ 48 mmol/mol) should be diagnosed and managed as having overt DIP. Before 20 weeks' gestation, and ideally between ten and 14 weeks' gestation, if tolerated, women with a previous history of gestational diabetes mellitus or early pregnancy HbA<sub>1c</sub> ≥ 6.0-6.4% (≥ 42-47 mmol/mol), but without diagnosed diabetes, should be advised to undergo a 75 g two-hour POGTT. All women (without diabetes already detected in the current pregnancy) should be advised to undergo a 75 g two-hour POGTT at 24-28 weeks' gestation.</p><p><strong>Changes in management as a result from this consensus statement: </strong>These updated recommendations raise the diagnostic glucose thresholds for gestational diabetes mellitus and clarify approaches to early pregnancy screening for women with risk factors for hyperglycaemia in pregnancy.</p>\",\"PeriodicalId\":18214,\"journal\":{\"name\":\"Medical Journal of Australia\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2025-06-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Journal of Australia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5694/mja2.52696\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Australia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5694/mja2.52696","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

在全球肥胖和糖尿病流行的背景下,妊娠期糖尿病和其他形式的高血糖在妊娠期越来越普遍。妊娠期高血糖与妇女和婴儿的短期和长期并发症有关。这些来自澳大利亚妊娠糖尿病协会(ADIPS)的2025年共识建议更新了基于现有证据和利益相关者咨询的妊娠高血糖筛查、诊断和分类指南。主要建议:如果满足以下一项或多项标准,应在妊娠期的任何时间诊断妊娠期显性糖尿病(显性DIP):(i)空腹血糖(FPG)≥7.0 mmol/L;(ii) 75 g妊娠2小时口服葡萄糖耐量试验(POGTT)后2小时血浆葡萄糖(2hPG)≥11.1 mmol/L;和/或(iii)糖化血红蛋白(HbA1c)≥6.5%(≥48 mmol/mol)。无论是否妊娠,在75g 2小时POGTT期间,应根据以下一项或多项标准诊断妊娠糖尿病:(i) FPG≥5.3-6.9 mmol/L;(ii) 1小时血浆葡萄糖(1hPG)≥10.6 mmol/L;(iii) 2hPG≥9.0 ~ 11.0 mmol/L。妊娠期有高血糖危险因素的妇女应建议在妊娠早期测量HbA1c。HbA1c≥6.5%(≥48 mmol/mol)的女性应被诊断为显性DIP。妊娠20周之前,最好在妊娠10 - 14周之间,如果耐受,既往有妊娠糖尿病史或妊娠早期HbA1c≥6.0-6.4%(≥42-47 mmol/mol)但未确诊为糖尿病的妇女,应建议进行75 g 2小时POGTT。建议所有妇女(当前妊娠未发现糖尿病)在妊娠24-28周进行75克2小时POGTT。这一共识声明导致了管理方面的变化:这些更新的建议提高了妊娠期糖尿病的诊断血糖阈值,并明确了妊娠期有高血糖危险因素的妇女的妊娠早期筛查方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes.

Introduction: In the context of a global obesity and diabetes epidemic, gestational diabetes mellitus and other forms of hyperglycaemia in pregnancy are increasingly common. Hyperglycaemia in pregnancy is associated with short and long term complications for both the woman and her baby. These 2025 consensus recommendations from the Australasian Diabetes in Pregnancy Society (ADIPS) update the guidance for the screening, diagnosis and classification of hyperglycaemia in pregnancy based on available evidence and stakeholder consultation.

Main recommendations: Overt diabetes in pregnancy (overt DIP) should be diagnosed at any time in pregnancy if one or more of the following criteria are met: (i) fasting plasma glucose (FPG) ≥ 7.0 mmol/L; (ii) two-hour plasma glucose (2hPG) ≥ 11.1 mmol/L following a 75 g two-hour pregnancy oral glucose tolerance test (POGTT); and/or (iii) glycated haemoglobin (HbA1c) ≥ 6.5% (≥ 48 mmol/mol). Irrespective of gestation, gestational diabetes mellitus should be diagnosed using one or more of the following criteria during a 75 g two-hour POGTT: (i) FPG ≥ 5.3-6.9 mmol/L; (ii) one-hour plasma glucose (1hPG) ≥ 10.6 mmol/L; (iii) 2hPG ≥ 9.0-11.0 mmol/L. Women with risk factors for hyperglycaemia in pregnancy should be advised to have the HbA1c measured in the first trimester. Women with HbA1c ≥ 6.5% (≥ 48 mmol/mol) should be diagnosed and managed as having overt DIP. Before 20 weeks' gestation, and ideally between ten and 14 weeks' gestation, if tolerated, women with a previous history of gestational diabetes mellitus or early pregnancy HbA1c ≥ 6.0-6.4% (≥ 42-47 mmol/mol), but without diagnosed diabetes, should be advised to undergo a 75 g two-hour POGTT. All women (without diabetes already detected in the current pregnancy) should be advised to undergo a 75 g two-hour POGTT at 24-28 weeks' gestation.

Changes in management as a result from this consensus statement: These updated recommendations raise the diagnostic glucose thresholds for gestational diabetes mellitus and clarify approaches to early pregnancy screening for women with risk factors for hyperglycaemia in pregnancy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medical Journal of Australia
Medical Journal of Australia 医学-医学:内科
CiteScore
9.40
自引率
5.30%
发文量
410
审稿时长
3-8 weeks
期刊介绍: The Medical Journal of Australia (MJA) stands as Australia's foremost general medical journal, leading the dissemination of high-quality research and commentary to shape health policy and influence medical practices within the country. Under the leadership of Professor Virginia Barbour, the expert editorial team at MJA is dedicated to providing authors with a constructive and collaborative peer-review and publication process. Established in 1914, the MJA has evolved into a modern journal that upholds its founding values, maintaining a commitment to supporting the medical profession by delivering high-quality and pertinent information essential to medical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信